Andros Pharmaceuticals Co Ltd

NEW
ROCO:6917 (Taiwan)  
NT$ 32.05 +0.20 (+0.63%) Aug 11
At Loss
P/B:
3.45
Market Cap:
NT$ 1.78B ($ 55.18M)
Enterprise V:
NT$ 1.43B ($ 44.22M)
Volume:
122.91K
Avg Vol (2M):
250.80K
Trade In:
Volume:
122.91K
At Loss
Avg Vol (2M):
250.80K

Andros Pharmaceuticals Co Ltd (ROCO:6917) Dividend

Andros Pharmaceuticals Co Ltd (ROCO:6917) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:6917 Dividend

Does Andros Pharmaceuticals Co Ltd (ROCO:6917) pay a dividend?

Andros Pharmaceuticals Co Ltd (ROCO:6917) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Andros Pharmaceuticals Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Andros Pharmaceuticals Co Ltd has returned capital to shareholders via buybacks at a rate of -13.3% over the past 3 years.

What are dividend-paying alternatives to Andros Pharmaceuticals Co Ltd?

For dividend-paying alternatives in Andros Pharmaceuticals Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.